March 2021 - Pharmaceutical Market Europe

March 2021 - Pharmaceutical Market Europe
Published on 10 March 2021

Description:

Mapping the patient journey to improve support programmes, how UCB is treating severe disease, launching a new drug during a pandemic

Preview:

28 articles from this collection:
PME COVER
PME COVER
3 - Comment
3 - Comment
4 - PMEA launching soon
4 - PMEA launching soon
5 - Contents
5 - Contents
6-7 - News
6-7 - News
8-9 - Coronavirus news
8-9 - Coronavirus news
10-11 - Coronavirus news
10-11 - Coronavirus news
12 - Darwin’s medicine
12 - Darwin’s medicine
13 - Rohit Khanna
13 - Rohit Khanna
13 - Pharma Market Europe (PME) Rohit Khanna
14 - Mike Dixon
14 - Mike Dixon
15 - Stephanie Hall
15 - Stephanie Hall
16-17 - Building a better future for people living with severe diseases
16-17 - Building a better future for people living with severe diseases
18-19 - Japanese clinical trials
18-19 - Japanese clinical trials
18-19 - Pharma Market Europe Japanese clinical trials
20-21 - The promise of precision medicine
20-21 - The promise of precision medicine
22-24 - Reaching patients and HCPs during the pandemic
22-24 - Reaching patients and HCPs during the pandemic
25 - Rare Disease Day 2021
25 - Rare Disease Day 2021
26 - Research News
26 - Research News
28-30 - Mapping the patient journey
28-30 - Mapping the patient journey
31 - earthware
31 - earthware
32 - Hamell
32 - Hamell
33 - Purple Agency
33 - Purple Agency
34-35 - Patient support
34-35 - Patient support
36-37 -  COVID-19 vaccines
36-37 - COVID-19 vaccines
36-37 - Pharma Market Europe COVID-19 vaccines
38-40 - Appointments
38-40 - Appointments
41 - Healthcare Comms News
41 - Healthcare Comms News
42 - Q&A with Avril Lee
42 - Q&A with Avril Lee
43 - Recruitment
43 - Recruitment
44 - Communiqué Awards 2021
44 - Communiqué Awards 2021